“Over 330 Publications”
  • Home
  • Northwestern | Proteomics pr...

Northwestern | Proteomics, home of the National Resource for Translational and Developmental Proteomics (NRTDP) is developing better antibody-based test for Coronavirus, COVID-19 improved blood testing.

Leveraging state-of-the-art mass spectrometry programs and years of successful experience , Northwestern | Proteomics is prepared to offer Top Down mass spec analysis of SARS-CoV-2 proteins. The depth and accuracy of the data that Northwestern Proteomics can deliver about viral proteins could prove to be an invaluable resource in help identify a vaccine for the Coronavirus.

Researchers, around the world, are expending every effort to identify a potential vaccine for the virus. When they do, Northwestern | Proteomics is ready to analyze that vaccine and offer researchers the most accurate protein profile possible.

Recent News
Thursday, 21 May 2020 Northwestern | Proteomics prepares to meet the COVID-19 challenge. Learn More
Thursday, 3 October 2019 Dr. Neil Kelleher recognized by CBC as Success Story! Learn More
Wednesday, 16 November 2016 Department of Preventive Medicine Seminar Learn More
Friday, 4 November 2016 Northwestern Proteomics Core celebrates with the Chicago Cubs! Learn More
Thursday, 26 November 2015 Wisconsin Human Proteomics Symposium Learn More